Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen’s Spinraza Witnessed Robust Patient Demand in 1Q17
Biogen’s Spinraza Witnessed Robust Patient Demand in 1Q17
Biogen’s Spinraza Witnessed Robust Patient Demand in 1Q17
Submitted by
admin
on April 28, 2017 - 11:45am
Source:
Market Realist
News Tags:
Biogen
Spinraza
patients
SMA
spinal muscular atrophy
Headline:
Biogen’s Spinraza Witnessed Robust Patient Demand in 1Q17
Do Not Allow Advertisers to Use My Personal information
